Middle East and Africa Proteomics Market – Share, Outlook, Trends, Size and Forecast (2024 – 2032)

Proteomic refers to the study of the proteomes which includes the study of the proteins function and their structure that helps in diagnosis and treatment of different diseases and drug development.  A proteome is a group of proteins produced in an organism which differs from one cell to another cell and changes over time. Proteomics can give biological data for biological problems and has several technologies to study about proteomes in detail. Proteomics is applied in drug discovery, precision medicine and for various disease diagnosis.

The Middle East & Africa Proteomics Expression Market Segments Size & Growth:

The Middle East & Africa Proteomics Expression Market is accounted for $XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth an increase in demand for precision medicine for curing diseases like cancer, diabetes, and so on, technological developments also lead to the government and private funds, increase in research.However, expensive instruments and lack of skilled researchers hinder the growth of the proteomics expression market.

The Middle East & Africa Proteomics Expression Market Segments Share:

The Middle East & AfricaProteomics Expression Market is categorised into by service type which consists of data analysis & maintenance, quantitation services, analytical laboratory and so on. The analytical laboratory has the most significant share due to increasing research. By technology, proteomics expression market is segmented as chromatography, X-ray crystallography, and protein microarray. Among all protein, microarrays are expected to have high growth rate during the forecast period 2018-2024, due to its ability to produce a high number of outcomes with fewer samples. The application is segregated into drug discovery, clinical diagnosis. Clinical diagnosis is expected to have the most significant share in the market due to the understanding of proteins and its application.

By Geography, South Africa is dominating the proteomics expression market, and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalised medicine and R&D activities. Furthermore, Middle East is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.

The Middle East & Africa Proteomics Expression Market Segments Trends:

• The change of proteomics market from genomics to proteomics that has broad applications in drug and treating various chronic diseases.
• The development methods to monitor post-translational modifications will lead to the deep understanding of protein function which is also an emerging technology in proteomics.
• In November 2017, GE Healthcare acquired Novia Strategies to expand its healthcare consulting firm.

The Middle East & Africa Proteomics Expression Research Report:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
• Regional and the Middle East & Africa diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• PerkinElmer, Inc.
• Caprion Proteomics Inc.
• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Luminex Corporation